{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:01:47Z","timestamp":1768712507538,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,13]],"date-time":"2014-02-13T00:00:00Z","timestamp":1392249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12020-014-0182-5","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T15:35:29Z","timestamp":1392219329000},"page":"625-630","source":"Crossref","is-referenced-by-count":40,"title":["Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria"],"prefix":"10.1007","volume":"47","author":[{"given":"Miro \u0160imun","family":"Alebi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomislav","family":"Bulum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nata\u0161a","family":"Stojanovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lea","family":"Duvnjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,13]]},"reference":[{"key":"182_CR1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"R.J. Norman, D. Dewailly, R.S. Legro, T.E. Hickey, Polycystic ovary syndrome. Lancet 370, 685\u2013697 (2007)","journal-title":"Lancet"},{"key":"182_CR2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","volume":"25","author":"WA March","year":"2010","unstructured":"W.A. March, V.M. Moore, K.J. Willson, D.I. Phillips, R.J. Norman, M.J. Davies, The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum. Reprod. 25, 544\u2013551 (2010)","journal-title":"Hum. Reprod."},{"key":"182_CR3","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","volume":"27","author":"BO Yildiz","year":"2012","unstructured":"B.O. Yildiz, G. Bozdag, Z. Yapici, I. Esinler, H. Yarali, Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 27, 3067\u20133073 (2012)","journal-title":"Hum. Reprod."},{"key":"182_CR4","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","volume":"166","author":"F \u00c1lvarez-Blasco","year":"2006","unstructured":"F. \u00c1lvarez-Blasco, J.I. Botella-Carretero, J.L. San Mill\u00e1n, H.F. Escobar-Morreale, Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch. Intern. Med. 166, 2081\u20132086 (2006)","journal-title":"Arch. Intern. Med."},{"key":"182_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"B.C. Fauser, B.C. Tarlatzis, R.W. Rebar, R.S. Legro, A.H. Balen, R. Lobo et al., Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28\u201338 (2012)","journal-title":"Fertil. Steril."},{"key":"182_CR6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","volume":"33","author":"E Diamanti-Kandarakis","year":"2012","unstructured":"E. Diamanti-Kandarakis, A. Dunaif, Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981\u20131030 (2012)","journal-title":"Endocr. Rev."},{"key":"182_CR7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","volume":"15","author":"L Moran","year":"2009","unstructured":"L. Moran, H. Teede, Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum. Reprod. Update 15, 477\u2013488 (2009)","journal-title":"Hum. Reprod. Update"},{"key":"182_CR8","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","volume":"26","author":"JF Ascaso","year":"2003","unstructured":"J.F. Ascaso, S. Pardo, J.T. Real, R.I. Lorente, A. Priego, R. Carmena, Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26, 3320\u20133325 (2003)","journal-title":"Diabetes Care"},{"key":"182_CR9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"T.M. Wallace, J.C. Levy, D.R. Matthews, Use and abuse of HOMA modeling. Diabetes Care 27, 1487\u20131495 (2004)","journal-title":"Diabetes Care"},{"key":"182_CR10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3109\/09513590.2013.774362","volume":"29","author":"F Lunger","year":"2013","unstructured":"F. Lunger, L. Wildt, B. Seeber, Accurate screening for insulin resistance in PCOS women using fasting insulin concentrations. Gynecol. Endocrinol. 29, 541\u2013544 (2013)","journal-title":"Gynecol. Endocrinol."},{"key":"182_CR11","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","volume":"38","author":"A Dunaif","year":"1989","unstructured":"A. Dunaif, K.R. Segal, W. Futterweit, A. Dobrjansky, Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165\u20131174 (1989)","journal-title":"Diabetes"},{"key":"182_CR12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.tem.2007.08.001","volume":"18","author":"HJ Teede","year":"2007","unstructured":"H.J. Teede, S.K. Hutchison, S. Zoungas, The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol. Metab. 18, 273\u2013279 (2007)","journal-title":"Trends Endocrinol. Metab."},{"key":"182_CR13","doi-asserted-by":"crossref","unstructured":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil. Steril. 81, 19\u201325 (2004)","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"182_CR14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","volume":"140","author":"R Hatch","year":"1981","unstructured":"R. Hatch, R.L. Rosenfield, M.H. Kim, D. Tredway, Hirsutism: implications, etiology, and management. Am. J. Obstet. Gynecol. 140, 815\u2013830 (1981)","journal-title":"Am. J. Obstet. Gynecol."},{"key":"182_CR15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","volume":"9","author":"AH Balen","year":"2003","unstructured":"A.H. Balen, J.S.E. Laven, S.L. Tan, D. Dewailly, The ultrasound assessment of the polycystic ovary: international consensus definitions. ASRM\/ESHRE consensus meeting on polycystic ovary syndrome. Hum. Reprod. Update 9, 505\u2013514 (2003)","journal-title":"Hum. Reprod. Update"},{"key":"182_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.fertnstert.2009.02.073","volume":"94","author":"S Livadas","year":"2010","unstructured":"S. Livadas, G. Boutzios, F. Economou, K. Alexandraki, X. Xyrafis, M. Christou et al., The effect of oral micronized progesterone on hormonal and metabolic parameters in anovulatory patients with polycystic ovary syndrome. Fertil. Steril. 94, 242\u2013246 (2010)","journal-title":"Fertil. Steril."},{"key":"182_CR17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF00280883","volume":"28","author":"D Matthews","year":"1985","unstructured":"D. Matthews, J. Hosker, A. Rudenski, B. Naylor, D. Treacher, R. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28, 12\u201319 (1985)","journal-title":"Diabetologia"},{"key":"182_CR18","first-page":"165","volume":"84","author":"RS Legro","year":"1999","unstructured":"R.S. Legro, A.R. Kunselman, W.C. Dodson, A. Dunaif, Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J. Clin. Endocrinol. Metab. 84, 165\u2013169 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"182_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","volume":"22","author":"DA Ehrmann","year":"1999","unstructured":"D.A. Ehrmann, R.B. Barnes, R.L. Rosenfield, M.K. Cavaghan, J. Imperial, Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141\u2013146 (1999)","journal-title":"Diabetes Care"},{"key":"182_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","volume":"16","author":"LJ Moran","year":"2010","unstructured":"L.J. Moran, M.L. Misso, R.A. Wild, R.J. Norman, Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 16, 347\u2013363 (2010)","journal-title":"Hum. Reprod. Update"},{"key":"182_CR21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diab.45.11.1547","volume":"45","author":"AJ Karter","year":"1996","unstructured":"A.J. Karter, E.J. Mayer-Davis, J.V. Selby, R.B. D\u2019Agostino Jr, S.M. Haffner, P. Sholinsky et al., Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 45, 1547\u20131555 (1996)","journal-title":"Diabetes"},{"key":"182_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","volume":"113","author":"J Lord","year":"2006","unstructured":"J. Lord, R. Thomas, B. Fox, U. Acharya, T. Wilkin, The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG 113, 1203\u20131209 (2006)","journal-title":"BJOG"},{"key":"182_CR23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/des463","volume":"28","author":"NK Stepto","year":"2013","unstructured":"N.K. Stepto, S. Cassar, A.E. Joham, S.K. Hutchison, C.L. Harrison, R.F. Goldstein et al., Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum. Reprod. 28, 777\u2013784 (2013)","journal-title":"Hum. Reprod."},{"key":"182_CR24","first-page":"25","volume":"33","author":"K Fi\u0161ter","year":"2009","unstructured":"K. Fi\u0161ter, I. Kol\u010di\u0107, S.M. Milanovi\u0107, J. Kern, The prevalence of overweight, obesity and central obesity in six regions of Croatia: results from the Croatian Adult Health Survey. Coll. Antropol. 33, 25\u201329 (2009)","journal-title":"Coll. Antropol."},{"key":"182_CR25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1365-2265.2010.03934.x","volume":"74","author":"S Franks","year":"2011","unstructured":"S. Franks, When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome? Clin. Endocrinol. (Oxf) 74, 148\u2013151 (2011)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"182_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0303-7207(02)00114-4","volume":"192","author":"PR Kezele","year":"2002","unstructured":"P.R. Kezele, E.E. Nilsson, M.K. Skinner, Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol. Cell. Endocrinol. 192, 37\u201343 (2002)","journal-title":"Mol. Cell. Endocrinol."},{"key":"182_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(99)00244-0","volume":"163","author":"P Monget","year":"2000","unstructured":"P. Monget, C. Bondy, Importance of the IGF system in early folliculogenesis. Mol. Cell. Endocrinol. 163, 89\u201393 (2000)","journal-title":"Mol. Cell. Endocrinol."},{"key":"182_CR28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1210\/jcem.82.2.3727","volume":"82","author":"AM Fulghesu","year":"1997","unstructured":"A.M. Fulghesu, P. Villa, V. Pavone, M. Guido, R. Apa, A. Caruso et al., The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82, 644\u2013648 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"182_CR29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humrep\/13.3.567","volume":"13","author":"PO Dale","year":"1998","unstructured":"P.O. Dale, T. Tanbo, E. Haug, T. Abyholm, The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Hum. Reprod. 13, 567\u2013570 (1998)","journal-title":"Hum. Reprod."},{"key":"182_CR30","first-page":"465","volume":"37","author":"DP Baldani","year":"2013","unstructured":"D.P. Baldani, L. \u0160krgati\u0107, M.S. Goldstajn, H. Vr\u010di\u0107, T. \u010cani\u0107, M. Strelec, Clinical, hormonal and metabolic characteristics of polycystic ovary syndrome among obese and nonobese women in the Croatian population. Coll. Antropol. 37, 465\u2013470 (2013)","journal-title":"Coll. Antropol."},{"key":"182_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1373\/clinchem.2010.152025","volume":"57","author":"FH Safar","year":"2011","unstructured":"F.H. Safar, O.A. Mojiminiyi, H.M. Al-Rumaih, M.F. Diejomaoh, Computational methods are significant determinants of the associations and definitions of insulin resistance using the homeostasis model assessment in women of reproductive age. Clin. Chem. 57, 279\u2013285 (2011)","journal-title":"Clin. Chem."},{"key":"182_CR32","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.fertnstert.2004.11.070","volume":"83","author":"CM DeUgarte","year":"2005","unstructured":"C.M. DeUgarte, A.A. Bartolucci, R. Azziz, Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil. Steril. 83, 1454\u20131460 (2005)","journal-title":"Fertil. Steril."},{"key":"182_CR33","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1210\/jc.2010-2167","volume":"95","author":"TA Buchanan","year":"2010","unstructured":"T.A. Buchanan, R.M. Watanabe, A.H. Xiang, Limitations in surrogate measures of insulin resistance. J. Clin. Endocrinol. Metab. 95, 4874\u20134876 (2010)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0182-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0182-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0182-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:50Z","timestamp":1559440610000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0182-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,13]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0182-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,13]]}}}